SUSAN HAWRYLKIW
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family PHOENIX, AZ NPI 1457427445
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family AZ ABBVIE INC. All categories
General Payments — all program years on this page
$17,564.40
- Category: General Payments
- Program years: PY2021–2024
- Record count: 820
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $4,330.83 across 201 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $4,330.83 | 201 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $1,492.32 | 89 |
| EISAI INC. | $625.42 | 18 |
| Biogen, Inc. | $326.06 | 8 |
| Lilly USA, LLC | $247.28 | 8 |
| TG THERAPEUTICS, INC. | $181.95 | 4 |
| Averitas Pharma Inc. | $171.41 | 3 |
| ARGENX US, INC. | $151.46 | 6 |
| PFIZER INC. | $149.39 | 13 |
| Celgene Corporation | $145.83 | 15 |
| Alexion Pharmaceuticals, Inc. | $141.99 | 6 |
| Genentech USA, Inc. | $88.00 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $70.71 | 4 |
| SK Life Science, Inc. | $64.77 | 2 |
| Neurocrine BioSciences, Inc. | $58.51 | 2 |
| Abbott Laboratories | $55.68 | 3 |
| UCB, Inc. | $51.54 | 2 |
| Lundbeck LLC | $48.57 | 2 |
| CSL Behring | $34.43 | 1 |
| Medtronic, Inc. | $29.23 | 2 |
| Sumitomo Pharma America, Inc. | $27.32 | 2 |
| Acorda Therapeutics, Inc | $25.80 | 1 |
| Amgen Inc. | $25.65 | 1 |
| ACADIA Pharmaceuticals Inc | $22.50 | 1 |
| EMD Serono, Inc. | $20.36 | 1 |
| Otsuka America Pharmaceutical, Inc. | $20.35 | 1 |
| MDD US Operations, LLC | $19.59 | 1 |
| Neurelis, Inc. | $18.44 | 1 |
| GE HEALTHCARE | $16.27 | 1 |
By program year
Records — PY2024 (201)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.